Why Current Publication Practices May Distort Science
article has not abstract
Vyšlo v časopise:
Why Current Publication Practices May Distort Science. PLoS Med 5(10): e201. doi:10.1371/journal.pmed.0050201
Kategorie:
Essay
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.0050201
Souhrn
article has not abstract
Zdroje
1. ThalerRH
1988
Anomalies: The winner's curse.
J Econ Perspect
2
191
202
2. CoxJCIsaacRM
1984
In search of the winner's curse.
Econ Inq
22
579
592
3. DyerDKagelJH
1996
Bidding in common value auctions: How the commercial construction industry corrects for the winner's curse.
Manage Sci
42
1463
1475
4. HarrisonGWListJA
2007
Naturally occurring markets and exogenous laboratory experiments: A case study of the winner's curse
NBER Working Paper No. 13072
1
20
Cambridge (MA)
National Bureau of Economic Research
5. CapenECClappRVCampbellWM
1971
Competitive bidding in high-risk situations.
J Petrol Technol
23
641
653
6. CassingJDouglasRW
1980
Implications of the auction mechanism in baseball's free-agent draft.
South Econ J
47
110
121
7. DessauerJP
1981
Book publishing: What it is, what it does
2nd edition
New York
R. R. Bowker
8. HendricksKPorterRHBoudreauB
1987
Information, returns, and bidding behavior in OCS auctions: 1954–1969.
J Ind Econ
35
517
542
9. IoannidisJPA
2005
Contradicted and initially stronger effects in highly cited clinical research.
J Am Med Assoc
294
218
228
10. KrzyzanowskaMKPintilieMTannockIF
2003
Factors associated with failure to publish large randomized trials presented at an oncology meeting.
J Am Med Assoc
290
495
501
11. SternJM
2006
Publication bias: Evidence of delayed publication in a cohort study of clinical research projects.
Br Med J
315
640
645
12. GoodmanSN
2008
Systematic reviews are not biased by results from trials stopped early for benefit.
J Clin Epidemiol
61
95
96
13. BasslerDFerreira-GonzalezIBrielMCookDJDevereauxPJ
2007
Systematic reviewers neglect bias that results from trials stopped early for benefit.
J Clin Epidemiol
60
869
873
14. IoannidisJP
2008
Why most discovered true associations are inflated.
Epidemiology
19
640
648
15. KavvouraFKLiberopoulosGIoannidisJPA
2007
Selection in reported epidemiological risks: An empirical assessment.
PLoS Med
4
e79
doi:10.1371/journal.pmed.0040079
16. KyzasPADenaxa-KyzaDIoannidisJP
2007
Almost all articles on cancer prognostic markers report statistically significant results.
Eur J Cancer
43
2559
2579
17. TurnerEHMatthewsAMLinardatosETellRARosenthalR
2008
Selective publication of antidepressant trials and its influence on apparent efficacy.
N Eng J Med
358
252
260
18. IoannidisJPATrikalinosTA
2005
Early extreme contradictory estimates may appear in published research: The Proteus phenomenon in molecular genetics research and randomized trials.
J Clin Epidemiol
58
543
549
19. IoannidisJPA
2005
Why most published research findings are false.
PLoS Med
2
e124
doi:10.1371/journal.pmed.0020124
20. EasterbrookPBerlinJAGopalanRMatthewsDR
1991
Publication bias in clinical research.
Lancet
337
867
872
21. IoannidisJP
2006
Evolution and translation of research findings: From bench to where.
PLoS Clin Trials
1
e36
doi:10.1371/journal.pctr.0010036
22. Contopoulos-IoannidisDGNtzaniEIoannidisJP
2003
Translation of highly promising basic science research into clinical applications.
Am J Med
114
477
484
23. National Human Genome Research Institute
2008
The Cancer Genome Atlas.
Available: http://www.genome.gov/17516564. Accessed 4 September 2008
24. FrankRHCookPJ
1995
The winner-take-all society
New York
Free Press
25. GoodmanSNAltmanDGGeorgeSL
1998
Statistical reviewing policies of medical journals: Caveat lector.
J Gen Intern Med
13
753
756
26. Biomed Central
2008
Most viewed articles in past year.
Available: http://www.biomedcentral.com/mostviewedbyyear/. Accessed 4 September 2008
27. The PLoS Medicine Editors
2006
The impact factor game.
PLoS Med
3
e291
doi:10.1371/journal.pmed.0030291
28. SmithR
2006
Commentary: The power of the unrelenting impact factor—Is it a force for good or harm.
Int J Epidemiol
35
1129
1130
29. AndersenJBelmontJChoCT
2006
Journal impact factor in the era of expanding literature.
J Microbiol Immunol Infect
39
436
443
30. HaTCTanSBSooKC
2006
The journal impact factor: Too much of an impact.
Ann Acad Med Singapore
35
911
916
31. SongFEastwoodABilbodySDuleyL
1999
The role of electronic journals in reducing publication bias.
Med Inform
24
223
229
32. RossnerMVan EppsHHillE
2007
Show me the data.
J Exp Med
204
3052
3053
33. ChewMVillanuevaEVvan der WeydenMB
2007
Life and times of the impact factor: Retrospective analysis of trends for seven medical journals (1994–2005) and their editors' views.
J Royal Soc Med
100
142
150
34. RoncoC
2006
Scientific journals: Who impacts the impact factor.
Int J Artif Organs
29
645
648
35. IoannidisJPA
2006
Concentration of the most-cited papers in the scientific literature: analysis of journal ecosystems.
PLoS ONE
1
e5
doi:10.1371/journal.pone.0000005
36. PanZTrikalinosTAKavvouraFKLauJIoannidisJP
2005
Local literature bias in genetic epidemiology: An empirical evaluation of the Chinese literature.
PLoS Med
2
e334
doi:10.1371/journal.pmed.0020334
37. IrelandNJ
1994
On limiting the market for status signals.
J Public Econ
53
91
110
38. BeckerGS
1991
A note on restaurant pricing and other examples of social influences on price.
Polit Econ
99
1109
1116
39. DasguptaPDavidPA
1994
Toward a new economics of science.
Res Pol
23
487
521
40. BikhchandaniSHirshleiferDWelchI
1998
Learning from the behavior of others: Conformity, fads, and informational cascades.
J Econ Perspect
12
151
170
41. HirshleiferDTeohSH
2003
Herd behaviour and cascading in capital markets: A review and synthesis.
Eur Financ Manage
9
25
66
42. RzhetskyALossifovILohJMWhiteKP
2007
Microparadigms: Chains of collective reasoning in publications about molecular interactions.
Proc Nat Acad Sci U S A
103
4940
4945
43. Nature
2008
Getting published in Nature: The editorial process.
Available: http://www.nature.com/nature/authors/get_published/index.html. Accessed 4 September 2008
44. Science
2008
About Science and AAAS.
Available: http://www.sciencemag.org/help/about/about.dtl. Accessed 4 September 2008
45. MertonRK
1957
Priorities in scientific discovery: A chapter in the sociology of science.
Am Sociol Rev
22
635
659
46. OlsonCMRennieDCookDDickersinKFlanaginA
2002
Publication bias in editorial decision making.
J Am Med Assoc
287
2825
2828
47. BrownAKraftDSchmitzSMSharplessVMartinC
2006
Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
Clin Gastroenterol Hepatol
4
1445
1451
48. PatsopoulosNAAnalatosAAIoannidisJPA
2006
Origin and funding of the most equently cited papers in medicine: Database analysis.
Br Med J
332
1061
1064
49. BubelaTMCaulfieldTA
2004
Do the print media “hype” genetic research? A comparison of newspaper stories and peer-reviewed research papers.
Canad Med Assoc J
170
1399
1407
50. PolanyiM
1964
Science, faith and society
2nd edition
Chicago
University of Chicago Press
51. DickersinKChanSChalmersTCSacksHSSmithHJr
1987
Publication bias and clinical trials.
Control Clin Trials
8
343
353
52. CallahamMLWearsRLWeberEJBartonCYoungG
1998
Positive-outcome bias and other limitations in the outcome of research abstracts submitted to a scientific meeting.
J Am Med Assoc
280
254
257
53. KahnemanD
2003
A perspective on judgment and choice: Mapping bounded rationality.
Am Psychol
58
697
720
54. IoannidisJPA
2006
Journals should publish all “null” results and should sparingly publish “positive” results.
Cancer Epidemiol Biomarkers Prev
15
185
55. PopperK
1959
The logic of scientific discovery
New York
Basic Books
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2008 Číslo 10
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
- Health Benefits of Universal Influenza Vaccination Strategy
- Off-Label Promotion, On-Target Sales
- Why Treatment Fails in Type 2 Diabetes